315 related articles for article (PubMed ID: 18214850)
21. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
Dasgupta A
Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
[TBL] [Abstract][Full Text] [Related]
22. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
23. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
[TBL] [Abstract][Full Text] [Related]
24. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
25. Drug interaction between St. John's wort and cyclosporine.
Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246
[TBL] [Abstract][Full Text] [Related]
26. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
[TBL] [Abstract][Full Text] [Related]
27. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.
Burstein AH; Horton RL; Dunn T; Alfaro RM; Piscitelli SC; Theodore W
Clin Pharmacol Ther; 2000 Dec; 68(6):605-12. PubMed ID: 11180020
[TBL] [Abstract][Full Text] [Related]
28. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
29. Effect of St John's wort on the pharmacokinetics of fexofenadine.
Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344
[TBL] [Abstract][Full Text] [Related]
30. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
Dasgupta A; Tso G; Szelei-Stevens K
J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
[TBL] [Abstract][Full Text] [Related]
31. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
32. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
[TBL] [Abstract][Full Text] [Related]
33. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A
Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267
[TBL] [Abstract][Full Text] [Related]
34. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
Dasgupta A; Hovanetz M; Olsen M; Wells A; Actor JK
Arch Pathol Lab Med; 2007 Jul; 131(7):1094-8. PubMed ID: 17616997
[TBL] [Abstract][Full Text] [Related]
35. Clinical herbal interactions with conventional drugs: from molecules to maladies.
Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
Clin Pharmacol Ther; 2002 Sep; 72(3):276-87. PubMed ID: 12235448
[TBL] [Abstract][Full Text] [Related]
37. St John's wort greatly decreases the plasma concentrations of oral S-ketamine.
Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Neuvonen PJ; Olkkola KT
Fundam Clin Pharmacol; 2012 Dec; 26(6):743-50. PubMed ID: 21635359
[TBL] [Abstract][Full Text] [Related]
38. The interaction between St John's wort and an oral contraceptive.
Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
[TBL] [Abstract][Full Text] [Related]
39. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.
Pfrunder A; Schiesser M; Gerber S; Haschke M; Bitzer J; Drewe J
Br J Clin Pharmacol; 2003 Dec; 56(6):683-90. PubMed ID: 14616430
[TBL] [Abstract][Full Text] [Related]
40. St John's wort: a hidden risk for transplant patients.
Turton-Weeks SM; Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
Prog Transplant; 2001 Jun; 11(2):116-20. PubMed ID: 11871046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
